PDL BioPharma, Inc. Payout ratio

Payout ratio of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Payout ratio growth rates and interactive chart.


Highlights and Quick Summary

  • Payout ratio for the quarter ending December 30, 2020 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Payout ratio decreased by -100.0%
  • Annual Payout ratio for 2020 was 0.0% (a -100.0% decrease from previous year)
  • Annual Payout ratio for 2019 was -0.01% (a -85.71% decrease from previous year)
  • Annual Payout ratio for 2018 was -0.07% (a -135.0% decrease from previous year)
  • Twelve month Payout ratio ending December 30, 2020 was 0.0% (a -100.0% decrease compared to previous quarter)
  • Twelve month trailing Payout ratio decreased by -100.0% year-over-year
Trailing Payout ratio for the last four month:
30 Dec '20 29 Jun '20 30 Mar '20 30 Dec '19
0.0% -0.01% -0.01% -0.01%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Payout ratio of PDL BioPharma, Inc.

Most recent Payout ratioof PDLI including historical data for past 10 years.

Interactive Chart of Payout ratio of PDL BioPharma, Inc.

PDL BioPharma, Inc. Payout ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.0% 0.0% 0.0% 0.0%
2019 -0.02% 0.0% 0.0% 0.0% -0.01%
2018 0.29% 0.0% 0.0% 0.0% -0.07%
2017 0.9% 0.0% 0.0% 0.29% 0.2%
2016 -1.45% 0.0% 197.69% 14.73% 26.07%
2015 24.54% 35.33% 31.35% 29.05% 29.54%
2014 44.35% 23.52% 26.12% 32.99% 29.96%
2013 34.48% 37.31% 22.38% 39.24% 31.76%
2012 42.62% 43.15% 28.52% 52.17% 39.66%
2011 53.8% 45.63% 29.95% 47.07% 42.04%
2010 -286.91% 0.0% 119.23% 141.54%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.